Top 5 High Tech Stocks To Own Right Now


Saudi Arabia’s sovereign credit rating was affirmed at A1 by Moody’s Investors Service on expectations that fiscal consolidation will continue over the medium term, stabilizing the government’s debt burden.

Moody’s expects the government’s ambitious structural reform agenda to "reduce the exposure of Saudi Arabia’s economy and public sector balance sheet to oil prices," according to the statement. The stable outlook indicates that the risks to the ratings are balanced, the agency said.

Saudi Arabia’s economy contracted 0.7 percent last year as the kingdom cut oil output and the private sector struggled with lower crude prices and rapid economic policy shifts meant to diversify and open up the oil-reliant economy.

Saudi Arabia raised $11 billion this week in the biggest dollar bond sale by an emerging market nation this year. The kingdom plans to borrow a total of $31 billion this year to bridge an expected budget deficit of $52 billion and fund its growth plans.

Top 5 High Tech Stocks To Own Right Now: Black Hills Corporation(BKH)


Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Black Hills (BKH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of Black Hills Corp (NYSE:BKH) have earned a consensus rating of “Hold” from the eight ratings firms that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $59.50.

  • [By Motley Fool Transcribing]

    Black Hills (NYSE:BKH) Q4 2018 Earnings Conference CallFeb. 8, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 High Tech Stocks To Own Right Now: Concert Pharmaceuticals, Inc.(CNCE)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) have earned a consensus rating of “Hold” from the nine brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $29.33.

  • [By Stephan Byrd]

    Concert Pharmaceuticals (NASDAQ:CNCE) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Thursday.

  • [By Max Byerly]

    Shares of Concert Pharmaceuticals (NASDAQ:CNCE) have been given an average rating of “Buy” by the nine research firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $27.80.

  • [By Shane Hupp]

    Concert Pharmaceuticals (NASDAQ:CNCE) last released its quarterly earnings results on Thursday, August 2nd. The biotechnology company reported ($0.57) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.05. Concert Pharmaceuticals had a negative return on equity of 19.73% and a net margin of 67.52%. equities research analysts expect that Concert Pharmaceuticals Inc will post -2.08 earnings per share for the current fiscal year.

  • [By Stephan Byrd]

    Media coverage about Concert Pharmaceuticals (NASDAQ:CNCE) has trended somewhat positive this week, Accern reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Concert Pharmaceuticals earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 46.0633525271097 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 5 High Tech Stocks To Own Right Now: Methode Electronics, Inc.(MEI)


Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Methode Electronics (MEI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ValuEngine cut shares of Methode Electronics (NYSE:MEI) from a hold rating to a sell rating in a research note published on Wednesday morning.

    MEI has been the topic of several other research reports. Zacks Investment Research lowered Methode Electronics from a buy rating to a hold rating in a research report on Saturday, February 24th. Robert W. Baird reissued an outperform rating and set a $51.00 target price (up previously from $48.00) on shares of Methode Electronics in a research report on Friday, March 2nd. Finally, TheStreet lowered Methode Electronics from a b rating to a c+ rating in a research report on Friday, March 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $48.75.

  • [By Logan Wallace]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Methode Electronics alerts:

    Analysts Expect Methode Electronics (MEI) Will Announce Quarterly Sales of $242.88 Million (americanbankingnews.com) Methode Electronics (MEI) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com) Analysts Anticipate Methode Electronics (MEI) Will Post Earnings of $0.74 Per Share (americanbankingnews.com) Commit To Buy Methode Electronics At $35, Earn 5.8% Annualized Using Options (nasdaq.com)


    Shares of Methode Electronics opened at $41.75 on Tuesday, Marketbeat reports. Methode Electronics has a 12-month low of $41.85 and a 12-month high of $42.60. The company has a market capitalization of $1.56 billion, a P/E ratio of 16.37, a price-to-earnings-growth ratio of 0.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.03 and a quick ratio of 3.47.

  • [By Motley Fool Staff]

    Methode Electronics (NYSE:MEI) Q4 2018 Earnings Conference CallJun. 21, 2018 11:00 a.m. ET


    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 High Tech Stocks To Own Right Now: NTT DOCOMO, Inc(DCM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of NTT Docomo Inc (NYSE:DCM) have been given an average recommendation of “Hold” by the seven research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company.

  • [By Logan Wallace]

    Bank of Hawaii bought a new position in NTT Docomo Inc (NYSE:DCM) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,664 shares of the technology company’s stock, valued at approximately $222,000.

  • [By Shane Hupp]

    DATA Communications Management Corp (TSE:DCM) insider Michael Sifton purchased 12,500 shares of DATA Communications Management stock in a transaction that occurred on Wednesday, September 12th. The stock was bought at an average cost of C$1.52 per share, for a total transaction of C$19,000.00.

Top 5 High Tech Stocks To Own Right Now: Duke Realty Corporation(DRE)


Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Duke Realty Corp  (NYSE:DRE)Q4 2018 Earnings Conference CallJan. 31, 2019, 3:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Legal & General Group Plc grew its holdings in shares of Duke Realty Corp (NYSE:DRE) by 10.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,957,540 shares of the real estate investment trust’s stock after acquiring an additional 275,717 shares during the period. Legal & General Group Plc owned about 0.83% of Duke Realty worth $78,303,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    Redpoint Investment Management Pty Ltd lowered its stake in Duke Realty Corp (NYSE:DRE) by 12.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,995 shares of the real estate investment trust’s stock after selling 2,457 shares during the period. Redpoint Investment Management Pty Ltd’s holdings in Duke Realty were worth $522,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Caisse DE Depot ET Placement DU Quebec decreased its holdings in Duke Realty Corp (NYSE:DRE) by 37.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,300 shares of the real estate investment trust’s stock after selling 6,651 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Duke Realty were worth $328,000 at the end of the most recent reporting period.

Leave a Reply

Your email address will not be published.